Skip to main content
Clinical Trials/IRCT20220614055170N1
IRCT20220614055170N1
Not yet recruiting
未知

Investigating the effect of guided mental imagery on motor dysfunction and balance of patients with multiple sclerosis (MS)

Kerman University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kerman University of Medical Sciences
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Suffering from Multiple Sclerosis such as Relapsing\-Remitting MS (RRMS), Primary progressive MS and Secondary progressive MS with the confirmation and diagnosis of the relevant doctor
  • Ability to communicate in Persian
  • Acceptable speaking ability
  • Acceptable listening ability to clearly hear the researcher's voice and the audio file
  • Age range between 18 and 60 years
  • The ability to walk at least 50 meters using the patient's usual mobility aids such as canes, walkers, etc. in a six\-minute walking test before the intervention
  • Not suffering from any primary neurological, psychological, cardiac, respiratory and other diseases such as osteoarthritis or rheumatoid arthritis, etc., which affect the patient's usual movement ability.
  • Failure to participate in a rehabilitation program or physical activity that improves and helps the disease for at least the last two months, or changing treatment in a way that affects the patient's mobility (physiotherapy or drug therapy)
  • No use of high doses of steroids in the past month, which is defined as high\-dose steroid therapy according to the following protocol: steroid use of 50 mg/day intravenously (IV) for six days, 40 mg intramuscularly (IM) for For more than 15 days, 20 mg intramuscularly for more than 30 days
  • Not experiencing any severe clinical relapse in the disease in the past month

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials